Sign Up For Our Newsletter
Sign Up For Our Newsletter

By

Stephanie Ciardi
REVANCE THERAPEUTICS: THE PRESTIGE MEDICAL AESTHETIC BIOTECH Revance is a Silicon Valley-based biotechnology company daring to make a difference by focusing on innovative aesthetic and therapeutic offerings, featuring its next-generation investigational neuromodulator product, DaxibotulinumtoxinA for Injection (DAXI). The company is progressing a portfolio of products and service across aesthetic medicine and underserved therapeutic specialties, including...
Read More
5 Critical Elements to Evaluating an Investment Real Estate Sponsor For over 28 years, investors with Timberland Partners have profited from the benefits afforded to private real estate investors. But today, there are more sponsors than ever soliciting capital and promising to deliver superior returns. As an investor, your ability to separate the average from...
Read More
The Next Pandemic: Plan, Prepare, Protect By John Loudon, President, Gonzalez Family Offices Somedays it seems the world is on fire. And recently, it actually has been. Virus shutdowns. Riots. Protests. Economic uncertainty. Government overreach. In the midst of all this, we have to plan to for future. And for many of us, that’s not...
Read More
Can Physicians Recover Post-COVID 19? According to the Primary Care Collaborative (PCC), an industry association, physicians, in general, and primary care physicians in particular, are in extreme distress. According to the US government statistics, the largest distribution of the Payroll Protection Program (PPP) loans went to a broad spectrum of healthcare and social services employers....
Read More
Timberland Partners is a Minneapolis-based real estate investment and management company focused exclusively on the multifamily apartment sector. In business for over 28 years, Timberland Partners owns and operates a +17,000-unit, $2 billion portfolio across the central and southeastern United States. The company specializes in value-add investments across growing secondary and tertiary markets. The company’s...
Read More
The Research & Development Tax Credit Helping You Get Cash Back Into Your Business! With businesses still reeling from the effects of the Corona Virus, the biggest fear we hear is that many believe that without things returning back to “normal” very soon, more businesses are going to fail. We hear this time and time...
Read More
Client Spotlight: PYC Therapeutics PYC Therapeutics is part of the ‘precision medicine’ revolution targeting rare genetic diseases. The company combines world-class expertise in RNA drug design with propriety intracellular delivery technology to develop highly precise and safe medicines. Company highlights include: Proven RNA expertise – PYC’s Chief of R&D has co-invented two FDA approved drugs...
Read More
AN ALTERNATIVE TO MONEY MARKET FUNDS By Don Ames, Sarasota Family Office Association June is behind us and July started off with a bang ahead of the 4th of July weekend. Last Thursday’s Nonfarm Payroll Report helped stocks roar ahead as a record 4.8 million jobs were created in June. According to Dow Jones, economists...
Read More
How alternative asset managers and family offices can use IQ-EQ Cosmos to counter COVID-19 challenges Bas Horsten, Sales & Business Development Director, Caribbean and Latin America, IQ-EQ The COVID-19 outbreak is changing the way that businesses around the world are operating. How can alternative asset managers and family offices leverage the right technological platforms to...
Read More
The future of the gig economy and how it may affect your business or investment. The current pandemic has seen unemployment rise to 15% as of April and dropped to 13.3% in May. This means that millions of people are looking for new ways to earn money to pay their household bills and survive. Companies...
Read More
1 17 18 19 20 21 28